BamSEC and AlphaSense Join Forces
Learn More

IVERIC bio Inc

Formerly NASDAQ: ISEE
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 106 pages Agreement and Plan of Merger Among: IVERIC Bio, Inc., a Delaware Corporation; Astellas US Holding, Inc., a Delaware Corporation; Berry Merger Sub, Inc., a Delaware Corporation; and Solely as Provided by Section ‎8.10(b) of This Agreement, Astellas Pharma Inc., a Company Organized Under the Laws of Japan Dated as of April 28, 2023
12/34/56
EX-2.1
from DEFA14A 106 pages Agreement and Plan of Merger Among: IVERIC Bio, Inc., a Delaware Corporation; Astellas US Holding, Inc., a Delaware Corporation; Berry Merger Sub, Inc., a Delaware Corporation; and Solely as Provided by Section ‎8.10(b) of This Agreement, Astellas Pharma Inc., a Company Organized Under the Laws of Japan Dated as of April 28, 2023
12/34/56
EX-2.3
from 10-K 12 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Opus Genetics Inc. Stock Issuance Agreement
12/34/56
EX-2.2
from 10-K 37 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Asset Purchase Agreement by and Between IVERIC bio Gene Therapy LLC and Opus Genetics Inc
12/34/56
EX-2.1
from 8-K 208 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Agreement and Plan of Merger by and Among Ophthotech Corporation, Orion Ophthalmology Merger Sub, Inc., Orion Ophthalmology LLC, Inception 4, Inc., And, Solely in Its Capacity as Company Equityholder Representative, Fortis Advisors LLC Dated as of October 30, 2018
12/34/56